Filter by
 

Type of content

Publication date

Keywords

Keywords

Target audience

treatment of drug use

Displaying 1 - 20 of 237

Events

1st International Seminar of the National Service for the Prevention and Rehabilitation of Drug and Alcohol Consumption (SENDA)

23.11.2021

The 1st International Seminar organised by the National Service for the Prevention and Rehabilitation of Drug and Alcohol Consumption (SENDA) of the Ministry of Interior and Public Security of Chile...

Events

ISAM2021 Global Congress

19.11.2021

The ISAM (International Society of Addiction Medicine) 2021 takes place 19-21 November as a virtual event.

Publications

Health and social responses to drug problems: A European guide

18.10.2021

The Health and social responses to drug problems: a European guide 2021 was developed to support practitioners and policymakers in tackling the negative consequences of drug use. The guide is composed of four sets of miniguides that look at responses to a range of drug problems in Europe. Framing...

Events

INHSU 2021 Virtual conference

13.10.2021

The International Network on Health and Hepatitis in Substance Users (INHU) 2021 conference takes place online on 13-15 October 2021. The EMCDDA is attending the conference.

Events

EMCDDA webinar: Health and social responses to cannabis problems in Europe — time for a paradigm shift?

08.10.2021

Objective: To kick off the cannabis webinar series, opening the debate with an all-encompassing overview of the key issues and response options available. Background: Cannabis is the most widely...

News

Six steps to improve the quality of drug services and systems — EMCDDA launches new practical manual for decision-makers

28.09.2021

Six steps to help improve the quality of drug services and systems in Europe are presented today in a new manual from the EU drugs agency (EMCDDA). Entitled Implementing quality standards for drug services and systems: a six-step guide to support quality assurance, the publication offers practical...

Publications

Implementing quality standards for drug services and systems: a six-step guide to support quality assurance

28.09.2021

This publication provides a practical introduction to the area of quality standards and quality assurance mechanisms and the key steps involved in their implementation in drug services and systems. The primary audience for this guide is those responsible for commissioning, planning or providing...

Events

EMCDDA webinar: Prison and drugs in Europe: current and future challenges

30.06.2021

Objective: to discuss the results of the report Prison and drugs in Europe: current and future challenges Insights with key customers. Invited Stakeholders: Heino Stöver, Institute for Addiction...

Events

ISSUP Italy: challenges and perspectives in addictions

28.06.2021

ISSUP Italy: challenges and perspectives in addictions meeting takes place on 28 June 2021 as an online event. ISSUP (International Society of Substance Use Professionals) Italy, hosted by the ...

Publications

Prison and drugs in Europe: current and future challenges

25.06.2021

This publication provides an overview of current knowledge and the latest developments in the field of drug use and prison in Europe. The report explores in depth the epidemiology of drug use and drug-related problems among the prison population, the available social and health service responses to...

Events

Treatment and Treatment Demand Indicator (TDI) expert meeting

16.06.2021

The annual Treatment Demand Indicator (TDI) and Treatment meeting, gathering experts from the EU member states and IPA 7 partners, takes place from 16-18 June 2021, online.  

Data

Statistical Bulletin 2021 — treatment demand data

09.06.2021

Events

Final meeting of the project ‘Minimal drug-treatment data set: data collection in Western Balkans'

03.06.2021

The IPA7 project has launched in 2020, a project to establish routine data collection on drug treatment in the Western Balkans with the objective of assisting the  national experts and national drug...

Document library

Using the evidence-based model for improving opioid agonist treatment scale-up in Ukraine

01.06.2021

Providing opioid agonist therapy (OAT) for people who inject drugs (PWID) is the worldwide strategy for reducing injection drug use and the spread of HIV, HCV and TB. As of January 2020 in Ukraine,...

Publications

Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons

30.04.2021

Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and drug markets have been impacted, as have the services...

News

EMCDDA releases third trendspotter study on COVID-19 and drugs

30.04.2021

In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies in 2020 on the effects of the pandemic on drug use and services, the report identifies new trends and...

News

Maximising access to drug treatment while minimising diversion of medications — new EMCDDA report looks at striking the balance

11.02.2021

Opioid substitution treatment (OST) is a key evidence-based tool used to manage opioid dependence and improve related health and social consequences. Yet increasing reports of the diversion and misuse of the controlled drugs used in this treatment in Europe are a cause for concern. In a new report...

Events

Launch of report: Balancing access to OST with preventing the diversion of opioid substitution medications in Europe: challenges and implications

11.02.2021

Read about the report in the news section. Read the full report here >>

Publications

Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe: challenges and implications

10.02.2021

This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications. It looks at how OST medications are diverted to the illicit market, the motivations behind...

Document library

Impact of the COVID-19 epidemic on drug markets, substance use patterns, and delivery of harm reduction and treatment services in Ukraine

01.02.2021

This mixed-methods study was conducted to monitor the trends in the drug scene, substance use practices, and availability of prevention and treatment services for people who use drugs in Ukraine in...

Loading